Hugel Inc - Asset Resilience Ratio

Latest as of June 2026: 29.08%

Hugel Inc (145020) has an Asset Resilience Ratio of 29.08% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hugel Inc (145020) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩346.63 Billion

≈ $234.91 Million USD Cash + Short-term Investments

Total Assets

₩1.19 Trillion

≈ $807.81 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Hugel Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 145020 total asset value.

Liquid Assets Composition Over Time

This chart breaks down Hugel Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Hugel Inc to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩346.63 Billion	29.08%
Total Liquid Assets	₩346.63 Billion	29.08%

Asset Resilience Insights

Very High Liquidity: Hugel Inc maintains exceptional liquid asset reserves at 29.08% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Hugel Inc Industry Peers by Asset Resilience Ratio

Compare Hugel Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for Hugel Inc (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Hugel Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	30.56%	₩329.07 Billion ≈ $223.01 Million	₩1.08 Trillion ≈ $729.76 Million	-14.48pp
2024-12-31	45.04%	₩423.12 Billion ≈ $286.74 Million	₩939.44 Billion ≈ $636.64 Million	-6.82pp
2023-12-31	51.86%	₩481.93 Billion ≈ $326.60 Million	₩929.25 Billion ≈ $629.74 Million	+1.95pp
2022-12-31	49.91%	₩523.99 Billion ≈ $355.10 Million	₩1.05 Trillion ≈ $711.42 Million	-4.77pp
2021-12-31	54.68%	₩552.13 Billion ≈ $374.17 Million	₩1.01 Trillion ≈ $684.28 Million	-7.98pp
2020-12-31	62.66%	₩599.20 Billion ≈ $406.07 Million	₩956.34 Billion ≈ $648.10 Million	-0.92pp
2019-12-31	63.58%	₩568.80 Billion ≈ $385.47 Million	₩894.69 Billion ≈ $606.32 Million	-1.93pp
2018-12-31	65.51%	₩601.56 Billion ≈ $407.67 Million	₩918.27 Billion ≈ $622.30 Million	-7.05pp
2017-12-31	72.56%	₩595.69 Billion ≈ $403.69 Million	₩820.93 Billion ≈ $556.33 Million	+37.19pp
2016-12-31	35.38%	₩104.11 Billion ≈ $70.55 Million	₩294.30 Billion ≈ $199.44 Million	+32.29pp
2015-12-31	3.08%	₩7.20 Billion ≈ $4.88 Million	₩233.57 Billion ≈ $158.29 Million	-9.54pp
2014-12-31	12.63%	₩12.28 Billion ≈ $8.32 Million	₩97.25 Billion ≈ $65.90 Million	--

pp = percentage points

About Hugel Inc

KQ:145020 Korea Biotechnology

Market Cap

$1.72 Billion

₩2.54 Trillion KRW

Market Cap Rank

#6704 Global

#163 in Korea

Share Price

₩235500.00

Change (1 day)

+1.51%

52-Week Range

₩214000.00 - ₩313500.00

All Time High

₩388000.00